AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Powered by AMiner. Clicking this button will take you away from SciOpen.
Home Food Science and Human Wellness Article
PDF (12.2 MB)
Cite
EndNote(RIS) BibTeX
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Open Access

Sodium butyrate alleviates fructose-induced non-alcoholic fatty liver disease by remodeling gut microbiota to promote γ-amino butyric acid production

Qu Chena,b, Lei Wua, Aijia Zhanga, Chen Wua, Liuping Caia, Yingping Xiaob, Yingdong Nia,( )
Key Laboratory of Animal Physiology and Biochemistry, Ministry of Agriculture and Rural Affairs, Nanjing Agricultural University, Nanjing 210095, China
State Key Laboratory for Managing Biotic and Chemical Threats to the Quality and Safety of Agro-products, Institute of Agro-product Safety and Nutrition, Zhejiang Academy of Agricultural Sciences, Hangzhou 310022, China

Peer review under responsibility of Tsinghua University Press.

Show Author Information

Abstract

Sodium butyrate (NaB) can regulate lipid metabolism and inhibit hepatic steatosis. This study aimed to investigate whether NaB can alleviate fructose-induced hepatic steatosis via remodeling the gut microbiota and evaluate the anti-fatty liver mechanisms. The results showed that NaB and NaB-remodeled gut microbiota significantly alleviated fructose-induced hepatic steatosis and increased plasma uric acid and fructose levels. Furthermore, both NaB and NaB-remodeled gut microbiota increased the abundance of Lactobacillus and altered the levels of plasma amino acids (upregulating gamma-amino butyric acid (GABA) and downregulating L-glutamic acid and L-arginine) in fructose-exposed mice. The correlation analysis showed that GABA levels positively correlated with Lactobacillus abundance, and increased GABA levels might promote the reduction of the hepatic triglyceride content. Further studies confirmed that GABA significantly reduced lipid deposition in mouse hepatocytes induced via fructose pretreatment in vitro. These findings suggested that NaB could ameliorate fructose-induced hepatic steatosis by regulating gut microbiota.

Keywords

Gut microbiotaFructoseButyrateHepatic steatosis

Electronic Supplementary Material

Download File(s)
fshw-13-2-961_ESM.docx (935.3 KB)

References

[1]

M.H. Le, Y.H. Yeo, X. Li, et al., 2019 Global NAFLD prevalence: a systematic review and meta-analysis, Clin. Gastroenterol. Hepatol. 20(12) (2022) 2809-2817. https://doi.org/10.1016/j.cgh.2021.12.002.
Crossref Google Scholar
[2]

H. Basciano, L. Federico, K. Adeli, Fructose, insulin resistance, and metabolic dyslipidemia, Nutr. Metab (Lond.) 2 (2005) 5. https://doi.org/10.1186/1743-7075-2-5.
Crossref Google Scholar
[3]

R.B. Canani, M.D. Costanzo, L. Leone, et al., Potential beneficial effects of butyrate in intestinal and extraintestinal diseases, World J. Gastroenterol. 17 (2011) 1519-1528. https://doi.org/10.3748/wjg.v17.i12.1519.
Crossref Google Scholar
[4]

G. Clarke, R.M. Stilling, P.J. Kennedy, et al., Minireview: gut microbiota: the neglected endocrine organ, Mol. Endocrinol. 28 (2014) 1221-1238. https://doi.org/10.1210/me.2014-1108.
Crossref Google Scholar
[5]

W.H. Zhang, Y. Jiang, Q.F. Zhu, et al., Sodium butyrate maintains growth performance by regulating the immune response in broiler chickens, Br. Poult. Sci. 52 (2011) 292-301. https://doi.org/10.1080/00071668.2011.578121.
Crossref Google Scholar
[6]

S. Ploger, F. Stumpff, G.B. Penner, et al., Microbial butyrate and its role for barrier function in the gastrointestinal tract, Ann. N.Y. Acad. Sci. 1258 (2012) 52-59. https://doi.org/10.1111/j.1749-6632.2012.06553.x.
Crossref Google Scholar
[7]

E. Chang, D.H. Kim, H. Yang, et al., CB1 receptor blockade ameliorates hepatic fat infiltration and inflammation and increases Nrf2-AMPK pathway in a rat model of severely uncontrolled diabetes, PLoS One 13 (2018) e0206152. https://doi.org/10.1371/journal.pone.0206152.
Crossref Google Scholar
[8]

B. Sun, Y. Jia, S. Yang, et al., Sodium butyrate protects against high-fat diet-induced oxidative stress in rat liver by promoting expression of nuclear factor E2-related factor 2, Br. J. Nutr. 122 (2019) 400-410. https://doi.org/10.1017/S0007114519001399.
Crossref Google Scholar
[9]

S. Khan, G. Jena, Sodium butyrate reduces insulin-resistance, fat accumulation and dyslipidemia in type-2 diabetic rat: a comparative study with metformin, Chem. Biol. Interact. 254 (2016) 124-134. https://doi.org/10.1016/j.cbi.2016.06.007.
Crossref Google Scholar
[10]

D. Zhou, Q. Pan, F.Z. Xin, et al., Sodium butyrate attenuates high-fat diet-induced steatohepatitis in mice by improving gut microbiota and gastrointestinal barrier, World J. Gastroenterol. 23 (2017) 60-75. https://doi.org/10.3748/wjg.v23.i1.60.
Crossref Google Scholar
[11]

R.B. Jones, T.L. Alderete, J.S. Kim, et al., High intake of dietary fructose in overweight/obese teenagers associated with depletion of Eubacterium and Streptococcus in gut microbiome, Gut Microbes. 10 (2019) 712-719. https://doi.org/10.1080/19490976.2019.1592420.
Crossref Google Scholar
[12]

J. Boursier, O. Mueller, M. Barret, et al., The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota, Hepatology 63 (2016) 764-775. https://doi.org/10.1002/hep.28356.
Crossref Google Scholar
[13]

P. Gkolfakis, G. Dimitriadis, K. Triantafyllou, Gut microbiota and nonalcoholic fatty liver disease, Hepatob. Pancreat. Dis. 14 (2015) 572-581. https://doi.org/10.1016/s1499-3872(15)60026-1.
Crossref Google Scholar
[14]

V. Tremaroli, F. Backhed, Functional interactions between the gut microbiota and host metabolism, Nature 489 (2012) 242-249. https://doi.org/10.1038/nature11552.
Crossref Google Scholar
[15]

W. Fang, H. Xue, X. Chen, et al., Supplementation with sodium butyrate modulates the composition of the gut microbiota and ameliorates highfat diet-induced obesity in mice, J. Nutr. 149 (2019) 747-754. https://doi.org/10.1093/jn/nxy324.
Crossref Google Scholar
[16]

G. den Besten, K. van Eunen, A.K. Groen, et al., The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism, J. Lipid Res. 54 (2013) 2325-2340. https://doi.org/10.1194/jlr.R036012.
Crossref Google Scholar
[17]

T.J. Borody, S. Paramsothy, G. Agrawal, Fecal microbiota transplantation: indications, methods, evidence, and future directions, Curr. Gastroenterol. Rep. 15 (2013) 337. https://doi.org/10.1007/s11894-013-0337-1.
Crossref Google Scholar
[18]

W.B. Dunn, D. Broadhurst, P. Begley, et al., Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry, Nat. Protoc. 6 (2011) 1060-1083. https://doi.org/10.1038/nprot.2011.335.
Crossref Google Scholar
[19]

E. Zelena, W.B. Dunn, D. Broadhurst, et al., Development of a robust and repeatable UPLC-MS method for the long-term metabolomic study of human serum, Anal. Chem. 81 (2009) 1357-1364. https://doi.org/10.1021/ac8019366.
Crossref Google Scholar
[20]

W. Chen, L. Gong, Z. Guo, et al., A novel integrated method for large-scale detection, identification, and quantification of widely targeted metabolites: application in the study of rice metabolomics, Mol. Plant. 6 (2013) 1769-1780. https://doi.org/10.1093/mp/sst080.
Crossref Google Scholar
[21]

E.J. Want, P. Masson, F. Michopoulos, et al., Global metabolic profiling of animal and human tissues via UPLC-MS, Nat. Protoc. 8 (2013) 17-32. https://doi.org/10.1038/nprot.2012.135.
Crossref Google Scholar
[22]

Y.C. Wang, S.N. Bleich, S.L. Gortmaker, Increasing caloric contribution from sugar-sweetened beverages and 100% fruit juices among US children and adolescents, 1988-2004, Pediatrics 121 (2008) e1604-14. https://doi.org/10.1542/peds.2007-2834.
Crossref Google Scholar
[23]

J.S. Sullivan, M.T. Le, Z. Pan, et al., Oral fructose absorption in obese children with non-alcoholic fatty liver disease, Pediatr. Obes. 10 (2015) 188-195. https://doi.org/10.1111/ijpo.238.
Crossref Google Scholar
[24]

M. Chung, J. Ma, K. Patel, et al., Fructose, high-fructose corn syrup, sucrose, and nonalcoholic fatty liver disease or indexes of liver health: a systematic review and meta-analysis, Am. J. Clin. Nutr. 100 (2014) 833-849. https://doi.org/10.3945/ajcn.114.086314.
Crossref Google Scholar
[25]

C. Sellmann, J. Priebs, M. Landmann, et al., Diets rich in fructose, fat or fructose and fat alter intestinal barrier function and lead to the development of nonalcoholic fatty liver disease over time, J. Nutr. Biochem. 26 (2015) 1183-1192. https://doi.org/10.1016/j.jnutbio.2015.05.011.
Crossref Google Scholar
[26]

T. Jensen, M.F. Abdelmalek, S. Sullivan, et al., Fructose and sugar: a major mediator of non-alcoholic fatty liver disease, J. Hepatol. 68 (2018) 1063-1075. https://doi.org/10.1016/j.jhep.2018.01.019.
Crossref Google Scholar
[27]

C.D. Kane, O.L. Francone, K.A. Stevens, Differential regulation of the cynomolgus, human, and rat acyl-CoA oxidase promoters by PPARalpha, Gene 380 (2006) 84-94. https://doi.org/10.1016/j.gene.2006.05.011.
Crossref Google Scholar
[28]

Y. Zhang, S. Li, W. Donelan, et al., Angiopoietin-like protein 8 (betatrophin) is a stress-response protein that down-regulates expression of adipocyte triglyceride lipase, Biochim. Biophys. Acta. 1861 (2016) 130-137. https://doi.org/10.1016/j.bbalip.2015.11.003.
Crossref Google Scholar
[29]

J.M. Orellana-Gavalda, L. Herrero, M.I. Malandrino, et al., Molecular therapy for obesity and diabetes based on a long-term increase in hepatic fatty-acid oxidation, Hepatology 53 (2011) 821-832. https://doi.org/10.1002/hep.24140.
Crossref Google Scholar
[30]

P. Ma, R. Huang, Y. Ou, A soy glycinin derived octapeptide protects against MCD diet induced non-alcoholic fatty liver disease in mice, Food Sci. Hum. Well. 11 (2022) 1544-1554. https://doi.org/10.1016/j.fshw.2022.06.012.
Crossref Google Scholar
[31]

S. Jung, H. Bae, W.S. Song, et al., Dietary fructose and fructose-induced pathologies, Annu. Rev. Nutr. 42 (2022) 45-66. https://doi.org/10.1146/annurev-nutr-062220-025831.
Crossref Google Scholar
[32]

M. Song, Dietary fructose induced gut microbiota dysbiosis is an early event in the onset of metabolic phenotype, FASEB J. 33 (2019) 723.2. https://doi.org/10.1096/fasebj.2019.33.1_supplement.723.2
Crossref Google Scholar
[33]

A.N. Payne, C. Chassard, C. Lacroix, Gut microbial adaptation to dietary consumption of fructose, artificial sweeteners and sugar alcohols: implications for host-microbe interactions contributing to obesity, Obes. Rev. 13 (2012) 799-809. https://doi.org/10.1111/j.1467-789X.2012.01009.x.
Crossref Google Scholar
[34]

L.K. Stenman, R. Burcelin, S. Lahtinen, Establishing a causal link between gut microbes, body weight gain and glucose metabolism in humans-towards treatment with probiotics, Benef. Microbes 7 (2016) 11-22. https://doi.org/10.3920/BM2015.0069.
Crossref Google Scholar
[35]

T.S. Kang, D.R. Korber, T. Tanaka, Regulation of dual glycolytic pathways for fructose metabolism in heterofermentative Lactobacillus panis PM1, Appl. Environ. Microbiol. 79 (2013) 7818-7826. https://doi.org/10.1128/AEM.02377-13.
Crossref Google Scholar
[36]

D.P. Neveling, A. Endo, L.M. Dicks, Fructophilic Lactobacillus kunkeei and Lactobacillus brevis isolated from fresh flowers, bees and bee-hives, Curr. Microbiol. 65 (2012) 507-515. https://doi.org/10.1007/s00284-012-0186-4.
Crossref Google Scholar
[37]

M. Rossi, C. Corradini, A. Amaretti, et al., Fermentation of fructooligosaccharides and inulin by bifidobacteria: a comparative study of pure and fecal cultures, Appl. Environ. Microbiol. 71 (2005) 6150-6158. https://doi.org/10.1128/AEM.71.10.6150-6158.2005.
Crossref Google Scholar
[38]

R. Fuller, Probiotics in man and animals, J. Appl. Bacteriol. 66 (1989) 365-378. https://doi.org/10.1111/j.1365-2672.1989.tb05105.x
Crossref Google Scholar
[39]

A. Azarang, O. Farshad, M.M. Ommati, et al., Protective role of probiotic supplements in hepatic steatosis: a rat model study, Biomed. Res. Int. 2020 (2020) 5487659. https://doi.org/10.1155/2020/5487659.
Crossref Google Scholar
[40]

E.E. Canfora, R.C.R. Meex, K. Venema, et al., Gut microbial metabolites in obesity, NAFLD and T2DM, Nat. Rev. Endocrinol. 15 (2019) 261-273. https://doi.org/10.1038/s41574-019-0156-z.
Crossref Google Scholar
[41]

C. Jang, S. Hui, W. Lu, et al., The small intestine converts dietary fructose into glucose and organic acids, Cell. Metab. 27 (2018) 351-361. https://doi.org/10.1016/j.cmet.2017.12.016.
Crossref Google Scholar
[42]

Y. Hou, W. Wei, X. Guan, et al., A diet-microbial metabolism feedforward loop modulates intestinal stem cell renewal in the stressed gut, Nat. Commun. 12 (2021) 271. https://doi.org/10.1038/s41467-020-20673-4.
Crossref Google Scholar
[43]

M.S. Su, S. Schlicht, M.G. Ganzle, Contribution of glutamate decarboxylase in Lactobacillus reuteri to acid resistance and persistence in sourdough fermentation, Microb. Cell Fact. 10(Suppl 1) (2011) S8. https://doi.org/10.1186/1475-2859-10-S1-S8.
Crossref Google Scholar
[44]

D. Dahiya, J.V. Manuel, P.S. Nigam, An overview of bioprocesses employing specifically selected microbial catalysts for gamma-aminobutyric acid production, Microorganisms 9 (2021) 2457. https://doi.org/10.3390/microorganisms9122457.
Crossref Google Scholar
[45]

Q. Wu, N.P. Shah, High gamma-aminobutyric acid production from lactic acid bacteria: emphasis on Lactobacillus brevis as a functional dairy starter, Crit. Rev. Food Sci. 57 (2017) 3661-3672. https://doi.org/10.1080/10408398.2016.1147418.
Crossref Google Scholar
[46]

X. Si, W. Shang, Z. Zhou, et al., Gamma-aminobutyric acid enriched rice bran diet attenuates insulin resistance and balances energy expenditure via modification of gut microbiota and short-chain fatty acids, J. Agric. Food Chem. 66 (2018) 881-890. https://doi.org/10.1021/acs.jafc.7b04994.
Crossref Google Scholar
Food Science and Human Wellness
Volume 13 Issue 2,
March 2024
Pages 961-971
DOI: 10.26599/FSHW.2022.9250082
Cite this article:
Chen Q, Wu L, Zhang A, et al. Sodium butyrate alleviates fructose-induced non-alcoholic fatty liver disease by remodeling gut microbiota to promote γ-amino butyric acid production. Food Science and Human Wellness, 2024, 13(2): 961-971. https://doi.org/10.26599/FSHW.2022.9250082

1314

Views

207

Downloads

1

Crossref

0

Web of Science

1

Scopus

0

CSCD

Altmetrics
Received: 26 July 2022
Revised: 29 September 2022
Accepted: 20 October 2022
Published: 25 September 2023
© 2024 Beijing Academy of Food Sciences. Publishing services by Tsinghua University Press.

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Return